Tilly H - Search Results

1

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.

Coiffier B, Thieblemont C, de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, Morschhauser F, Navarro R, Le Gouill S, Haioun C, Houot R, Casasnovas O, Holte H, Lamy T, Broussais F, Payrard S, Hatteville L, Tilly H. Coiffier B, et al. Among authors: tilly h. Br J Haematol. 2016 Jun;173(5):722-30. doi: 10.1111/bjh.13992. Epub 2016 Mar 24. Br J Haematol. 2016. PMID: 27010483 Free article. Clinical Trial.

2

[Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].

Salles G, Herbrecht R, Brice P, Sebbań C, Tilly H, Lederlin P, Berger F, Coiffier B. Salles G, et al. Among authors: tilly h. Ann Gastroenterol Hepatol (Paris). 1992 Jun-Sep;28(4):205-8. Ann Gastroenterol Hepatol (Paris). 1992. PMID: 1280028 Clinical Trial. French.

3

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J, et al. Bosly A, et al. Among authors: tilly h. J Clin Oncol. 1992 Oct;10(10):1615-23. doi: 10.1200/JCO.1992.10.10.1615. J Clin Oncol. 1992. PMID: 1383435

4

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al. Fenaux P, et al. Among authors: tilly h. Blood. 1992 Nov 1;80(9):2176-81. Blood. 1992. PMID: 1421389 Free article. Clinical Trial.

5

Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.

Salles G, Herbrecht R, Tilly H, Berger F, Brousse N, Gisselbrecht C, Coiffier B. Salles G, et al. Among authors: tilly h. Am J Med. 1991 Jan;90(1):77-84. doi: 10.1016/0002-9343(91)90509-v. Am J Med. 1991. PMID: 1702581 Clinical Trial.

6

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO. Coiffier B, et al. Among authors: tilly h. J Clin Oncol. 1991 Feb;9(2):211-9. doi: 10.1200/JCO.1991.9.2.211. J Clin Oncol. 1991. PMID: 1703226

7

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N. Coiffier B, et al. Among authors: tilly h. J Clin Oncol. 1989 Aug;7(8):1018-26. doi: 10.1200/JCO.1989.7.8.1018. J Clin Oncol. 1989. PMID: 2474057 Clinical Trial.

8

Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.

Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E, et al. Morel P, et al. Among authors: tilly h. Br J Cancer. 1994 Jul;70(1):154-9. doi: 10.1038/bjc.1994.267. Br J Cancer. 1994. PMID: 7517172 Free PMC article. Clinical Trial.

9

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D'Agay MF, et al. Haioun C, et al. Among authors: tilly h. J Clin Oncol. 1994 Dec;12(12):2543-51. doi: 10.1200/JCO.1994.12.12.2543. J Clin Oncol. 1994. PMID: 7527453 Clinical Trial.

10

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.

Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, et al. Dombret H, et al. Among authors: tilly h. N Engl J Med. 1995 Jun 22;332(25):1678-83. doi: 10.1056/NEJM199506223322504. N Engl J Med. 1995. PMID: 7539109 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

465 results

Search Page